Regional Left Ventricular Wall Thickening: Relation to Regional Uptake of 18Fluorodeoxyglucose and 201TI in Patients With Chronic Coronary Artery Disease and Left Ventricular Dysfunction

BackgroundIn previous studies comparing regional 201TI (201TI) and 18fluorodeoxyglucose (FDG) activity in patients with chronic coronary artery disease and left ventricular dysfunction, we hypothesized that regions with mild-to-moderate reduction in FDG activity and regions with mild-to-moderate irreversible 201TI defects after 3- to 4-hour redistribution represent viable myocardium. In the present study, regional FDG and 201TI activities were compared with regional systolic wall thickening by gated magnetic resonance imaging (MRI) to confirm the presence of viable myocardium in these territories Methods and ResultsTwenty-five patients with chronic stable coronary artery disease and left ventricular dysfunction (ejection fraction, 28±10) underwent exercise 201TI tomographic imaging (SPECT), using a reinjection protocol, positron emission tomography (PET) with FDG and H21550, and gated MRI. Matched SPECT, PET, and MRI tomograms were analyzed. From the PET data, 105 regions had matched reduction in FDG and blood flow, of which 69 regions had moderately reduced FDG uptake (50–79% uptake relative to a normal reference region) and 36 had severely reduced FDG uptake (<50% of normal activity). Regions with moderately reduced as compared with severely reduced FDG activity had greater end-diastolic wall thickness (9.4±2.6 versus 8.0±3.7 mm; p < 0.05) and regional systolic wall thickening (1.7±2.7 versus −0.7±2.1 mm; p < 0.01). From the SPECT data, 169 irreversible 201TI defedts after 3-4-hour redistribution were identified, of which 70 were mild (>65 to <85% of maximal 201TI activity), 52 were moderate (50–65% of maximal activity), and 47 were severe (<50% of maximal activity). Regional systolic wall thickening was greater in regions with normal 201TI uptake (3.3±2.3 mm) as compared with all other regions. Regions showing only mild or moderate irreversible defects at redistribution, however, showed wall thickening (2.4±2.4 and 2.2±2.5 mm, respectively), which was similar to that observed in regions with reversible 201TI defects (2.1±2.2 mm). Only regions with severe irreversible defects at redistribution showed absence of thickening (−0.1±2.9 mm, p < 0.01 versus all other groups). After 201TI reinjection, 12 of 47 (26%) regions with severe irreversible defects showed enhanced 201TI uptake. The impairment in regional systolic wall thickening was not significantly different between 201TI defects with and without enhanced 201TI uptake after reinjection. FDG activity, however, was present in all 12 regions (100%) with enhanced 201TI uptake after reinjection as compared with only five of 35 (14%) that were unchanged after reinjection (p < 0.01) ConclusionsTherefore, preserved wall thickness and systolic wall thickening in regions with moderate reduction in blood flow and FDG activity, and in irreversible 201TI defects that are only mild-to-moderate, provide additional evidence that such regions represent viable myocardium. Moreover, the finding of metabolic activity and 201TI uptake in regions with reduced blood flow and absent wall thickening provides clinical evidence of hibernating myocardium in humans.

[1]  E. Braunwald,et al.  Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". , 1986, Journal of the American College of Cardiology.

[2]  M E Phelps,et al.  Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia , 1983, Circulation.

[3]  Y. Yonekura,et al.  Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. , 1990, The American journal of cardiology.

[4]  C. Higgins,et al.  Regional left ventricular wall thickening by magnetic resonance imaging: evaluation in normal persons and patients with global and regional dysfunction. , 1987, The American journal of cardiology.

[5]  A. Bol,et al.  Regional Oxidative Metabolism in Patients After Recovery From Reperfused Anterior Myocardial Infarction: Relation to Regional Blood Flow and Glucose Uptake , 1992, Circulation.

[6]  L. Opie,et al.  Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. , 1989, Progress in cardiovascular diseases.

[7]  D. Berman,et al.  The frequency of late reversibility in SPECT thallium-201 stress-redistribution studies. , 1990, Journal of the American College of Cardiology.

[8]  Y. Yonekura,et al.  Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R. Bonow Identification of viable myocardium in patients with coronary artery disease and left ventricular dysfunction , 1993 .

[10]  M. Walsh,et al.  Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. , 1989, Journal of the American College of Cardiology.

[11]  G S Johnston,et al.  Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. , 1977, The New England journal of medicine.

[12]  Y. Yonekura,et al.  Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction. , 1988, The American journal of cardiology.

[13]  H. Schelbert,et al.  Insights Into Coronary Artery Disease Gained From Metabolic Imaging , 1988, Circulation.

[14]  C. Higgins,et al.  Magnetic resonance imaging of ischemic heart disease. , 1985, Progress in cardiovascular diseases.

[15]  A. Hakki,et al.  Thallium-201 myocardial scintigraphy. , 1985, American heart journal.

[16]  R. Peshock,et al.  Assessment of myocardial systolic wall thickening using nuclear magnetic resonance imaging. , 1989, Journal of the American College of Cardiology.

[17]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[18]  L. Kaufman,et al.  Imaging by nuclear magnetic resonance in patients with chronic ischemic heart disease. , 1984, Circulation.

[19]  R. Okada,et al.  The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: does it represent scar or ischemia? , 1985, American heart journal.

[20]  C. Tracy,et al.  The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia. , 1988, The American journal of cardiology.

[21]  V. Dilsizian,et al.  Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. , 1992, Circulation.

[22]  G. Taylor,et al.  Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. , 1983, Journal of the American College of Cardiology.

[23]  M. Phelps,et al.  Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. , 1987, Journal of the American College of Cardiology.

[24]  M. Phelps,et al.  Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. , 1986, Circulation.

[25]  M. Phelps,et al.  PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT. , 1989, Radiology.

[26]  R. Bonow,et al.  Arterial blood concentration curves by cardiac PET without arterial sampling or image reconstruction , 1988, Proceedings. Computers in Cardiology 1988.

[27]  J Ross,et al.  Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. , 1991, Circulation.

[28]  P. Herrero,et al.  Quantitation of myocardial blood flow with H2 15O and positron emission tomography: assessment and error analysis of a mathematical approach. , 1989, Journal of computer assisted tomography.

[29]  A. Fischman,et al.  Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. , 1990, The American journal of cardiology.

[30]  D. Berman,et al.  Use of Thallium‐201 Redistribution Scintigraphy in the Preoperative Differentiation of Reversible and Nonreversible Myocardial Asynergy , 1981, Circulation.

[31]  R. Gropler,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  Y. Yonekura,et al.  F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction. , 1988, The American journal of cardiology.

[33]  D. Berman,et al.  Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. , 1988, Journal of the American College of Cardiology.

[34]  Y. Yonekura,et al.  Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. , 1989, The American journal of cardiology.

[35]  S. Rahimtoola,et al.  The hibernating myocardium. , 1989, American heart journal.

[36]  E. Depuey,et al.  Incomplete redistribution in delayed thallium-201 single photon emission computed tomographic (SPECT) images: an overestimation of myocardial scarring. , 1988, Journal of the American College of Cardiology.